|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.167
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.126
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.125
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.115
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.113
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.113
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.111
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.104
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.091
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.090
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.087
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.086
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.081
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.080
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.079
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.079
|
|
|
post embryonic retina morphogenesis in camera type eye
|
GO:0060060 |
3 |
0.078
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.077
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.076
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.074
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.073
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.072
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.071
|
|
|
nephron development
|
GO:0072006 |
109 |
0.070
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.066
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.065
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.064
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.064
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.063
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.062
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.062
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.061
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.060
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.060
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.057
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.057
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.057
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.055
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.054
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.054
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.053
|
|
|
protein processing
|
GO:0016485 |
163 |
0.052
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.052
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.052
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.052
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.052
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.051
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.050
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.050
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.050
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.049
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.048
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.047
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.047
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.047
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.047
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.046
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.046
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.046
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.046
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.046
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.045
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.045
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.045
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.044
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.042
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.041
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.041
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.041
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.041
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.041
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.040
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.040
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.040
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.039
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.039
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.039
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.039
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.039
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.039
|
|
|
renal system development
|
GO:0072001 |
225 |
0.039
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.039
|
|
|
kidney development
|
GO:0001822 |
213 |
0.038
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.038
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.037
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.037
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.036
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.036
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.036
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.036
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.035
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.035
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.035
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.034
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.034
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.034
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.034
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.034
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.034
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.034
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.034
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.033
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.032
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.032
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.032
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.032
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.032
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.031
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.030
|
|
|
dendrite self avoidance
|
GO:0070593 |
2 |
0.030
|
|
|
recognition of apoptotic cell
|
GO:0043654 |
3 |
0.030
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.030
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.029
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.029
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.029
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.029
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.029
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.029
|
|
|
gonad development
|
GO:0008406 |
141 |
0.028
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.028
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.028
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.028
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.028
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.028
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.028
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.028
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.028
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.028
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.027
|
|
|
lung development
|
GO:0030324 |
164 |
0.026
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.026
|
|
|
defecation
|
GO:0030421 |
1 |
0.026
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.026
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.026
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.026
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.026
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.026
|
|
|
tube formation
|
GO:0035148 |
140 |
0.026
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.026
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.026
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.025
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.025
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.025
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.025
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.025
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.025
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.025
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
heterophilic cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0007157 |
20 |
0.025
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.025
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.025
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.024
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.024
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.024
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.024
|
|
|
bone development
|
GO:0060348 |
120 |
0.024
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.024
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.024
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.024
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.024
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.024
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.024
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.023
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.023
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.023
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.023
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.023
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.023
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.023
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.023
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.023
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.023
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.023
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.022
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.022
|
|
|
pallium development
|
GO:0021543 |
120 |
0.022
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.022
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.022
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.022
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.022
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.022
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.022
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.022
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.022
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.021
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.021
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.021
|
|
|
midgut development
|
GO:0007494 |
4 |
0.021
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.021
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.021
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.021
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.021
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.021
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.021
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.021
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.020
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.020
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.020
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.020
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.020
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.020
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.020
|
|
|
limb development
|
GO:0060173 |
166 |
0.020
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.020
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.020
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.020
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.020
|
|
|
appendage development
|
GO:0048736 |
166 |
0.020
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.020
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.019
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.019
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.019
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.019
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.019
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.019
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.019
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.019
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.019
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.019
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.019
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.019
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.019
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.018
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.018
|
|
|
regulation of alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor activity
|
GO:2000311 |
11 |
0.018
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.018
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.018
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
regulation of chromatin binding
|
GO:0035561 |
7 |
0.018
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.018
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.018
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.018
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.018
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
20 |
0.018
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.018
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.018
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.018
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.018
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.018
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.018
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.018
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.018
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.017
|
|
|
olfactory bulb axon guidance
|
GO:0071678 |
1 |
0.017
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.017
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.017
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.017
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.017
|
|
|
gland development
|
GO:0048732 |
330 |
0.017
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.017
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.017
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.017
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.017
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.017
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.017
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.017
|
|
|
spinal cord ventral commissure morphogenesis
|
GO:0021965 |
2 |
0.017
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.017
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.017
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.017
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.017
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.017
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.017
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.017
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.017
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.017
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.017
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.016
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.016
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.016
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.016
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.016
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.016
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.016
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.016
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.016
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
cervix development
|
GO:0060067 |
2 |
0.016
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.016
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.016
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.016
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.016
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.016
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.016
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.016
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.016
|
|
|
homophilic cell adhesion via plasma membrane adhesion molecules
|
GO:0007156 |
18 |
0.016
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.016
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.016
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.016
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.016
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.015
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.015
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.015
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.015
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.015
|
|
|
semaphorin plexin signaling pathway involved in bone trabecula morphogenesis
|
GO:1900220 |
2 |
0.015
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.015
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.015
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.015
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.015
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.015
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.015
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.015
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.015
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.015
|
|
|
fasciculation of motor neuron axon
|
GO:0097156 |
2 |
0.015
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.015
|
|
|
cell growth
|
GO:0016049 |
130 |
0.015
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.015
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.015
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.015
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.015
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.015
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.015
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.015
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.015
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.015
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.015
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.015
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.015
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.015
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.015
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.015
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.014
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
14 |
0.014
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.014
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.014
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.014
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.014
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.014
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.014
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.014
|
|
|
somite development
|
GO:0061053 |
81 |
0.014
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.014
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.014
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.014
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.014
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.014
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.014
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.014
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.014
|
|
|
ossification
|
GO:0001503 |
216 |
0.014
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.014
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.014
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.014
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.014
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.014
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.014
|
|
|
epithelial cell proliferation involved in prostatic bud elongation
|
GO:0060517 |
1 |
0.014
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.014
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.014
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.013
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.013
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.013
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.013
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.013
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.013
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
35 |
0.013
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.013
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.013
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.013
|
|
|
neuron death
|
GO:0070997 |
154 |
0.013
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.013
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.013
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.013
|
|
|
regulation of glutamate receptor signaling pathway
|
GO:1900449 |
16 |
0.013
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.013
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.013
|
|
|
postganglionic parasympathetic nervous system development
|
GO:0021784 |
2 |
0.013
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.013
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.013
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.013
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.013
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.013
|
|
|
insulin secretion involved in cellular response to glucose stimulus
|
GO:0035773 |
36 |
0.013
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.013
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.013
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.013
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.013
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.013
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.013
|
|
|
neuroblast division in subventricular zone
|
GO:0021849 |
2 |
0.013
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.012
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.012
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.012
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.012
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.012
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.012
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.012
|
|
|
tube closure
|
GO:0060606 |
91 |
0.012
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.012
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.012
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.012
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.012
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.012
|
|
|
positive regulation of gamma aminobutyric acid secretion
|
GO:0014054 |
2 |
0.012
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.012
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.012
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.012
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.012
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.012
|
|
|
cation transport
|
GO:0006812 |
399 |
0.012
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.012
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.012
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.012
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.012
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.012
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.012
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.012
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.012
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.012
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.012
|
|
|
cell division
|
GO:0051301 |
120 |
0.012
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.012
|
|
|
rna interference
|
GO:0016246 |
2 |
0.012
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.012
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.011
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.011
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.011
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.011
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.011
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.011
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.011
|
|
|
metanephric renal vesicle morphogenesis
|
GO:0072283 |
12 |
0.011
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.011
|
|
|
regulation of long term synaptic depression
|
GO:1900452 |
3 |
0.011
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.011
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.011
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.011
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.011
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.011
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.011
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.011
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.011
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.011
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.011
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.011
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.011
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.011
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.011
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.011
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.011
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.011
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.011
|
|
|
cellular response to heparin
|
GO:0071504 |
1 |
0.011
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.011
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.011
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.011
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.011
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.010
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.010
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.010
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.010
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.010
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.010
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.010
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.010
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.010
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.010
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.010
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.010
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.010
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.010
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.010
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.010
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.010
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.010
|
|